In lung adenocarcinoma PC9 and H1975 cells, pharmacological Axl inhibition with the selective Axl inhibitors bemcentinib and BGB324 markedly reduced PD-L1 and PD-L2 expression. The gene discussed is AXL; the disease is lung adenocarcinoma.